6550 South Millrock Drive, Suite G50
Salt Lake City, Utah 84121
October 4, 2023
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Lauren Hamill and Laura Crotty
Re: Clene Inc.
Acceleration Request for Registration Statement on Form S-3
File No. 333-274651
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Clene Inc. (the “Company”) hereby requests acceleration of the effective date of the above referenced registration statement (the “Registration Statement”) to 4:00 p.m., Eastern Time, on October 6, 2023, or as soon thereafter as practicable.
Please contact Tom McAleavey of Holland & Knight, special counsel to the Company, by email at email@example.com or by phone at (407) 244-5108 if you have any other questions or concerns regarding this matter.
[Signature Page Follows]
|/s/ Robert Etherington|
Name: Robert Etherington
Title: President and Chief Executive Officer